117 Grants (Page 3 of 5)
2013
Role of hematopoietic microenvironment in plexiform neurofibroma progression
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5P50NS052606-09), $358,270USD, 08/01/2013 -- 07/31/2014
2012
Fanconi Anemia stem cells allow molecular characterization of acute leukemia
Bagby, Grover C and Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA138237-05), $379,440USD, 09/30/2008 -- 07/31/2014
 
Genetic Therapy for Fanconi Anemia
Clapp, David W⋅HANENBERG, HELMUT and Yang, Feng Chun
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA155294-02), $319,550USD, 02/01/2011 -- 12/31/2015
 
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-15), $312,768USD, 04/01/1997 -- 02/28/2014
 
Role of hematopoietic microenvironment in plexiform neurofibroma progression
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5P50NS052606-08-7196), $363,662USD, 2012
2011
Fanconi Anemia stem cells allow molecular characterization of acute leukemia
Bagby, Grover C and Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA138237-04), $380,935USD, 09/30/2008 -- 07/31/2013
 
Genetic Therapy for Fanconi Anemia
Clapp, David W⋅HANENBERG, HELMUT and Yang, Feng Chun
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA155294-01), $319,550USD, 02/01/2011 -- 12/31/2015
 
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-14), $314,738USD, 04/01/1997 -- 02/28/2013
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5U01NS055849-04), $438,900USD, 2011
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5U01NS055849-04), $438,900USD, 07/01/2008 -- 06/30/2012
 
Role of hematopoietic microenvironment in plexiform neurofibroma progression
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5P50NS052606-07), $331,696USD, 08/01/2011 -- 07/31/2012
2010
Fanconi Anemia stem cells allow molecular characterization of acute leukemia
Bagby, Grover C and Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA138237-03), $394,298USD, 09/30/2008 -- 07/31/2013
 
Lentiviral Vectors for the Treatment of Fanconi Anemia
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R41HL099150-01), $223,172USD, 07/01/2010 -- 06/30/2011
 
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-13), $324,865USD, 04/01/1997 -- 02/28/2013
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5U01NS055849-03), $621,744USD, 07/01/2008 -- 06/30/2012
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5U01NS055849-03), $621,744USD, 2010
 
Role of hematopoietic microenvironment in plexiform neurofibroma progression
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 2P50NS052606-06), $326,453USD, 08/15/2010 -- 07/31/2011
2009
Evaluation of Genetic Therapy in Fancc and Fanca Mice
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-15-0003), $438,682USD, 2009
 
Fanconi Anemia stem cells allow molecular characterization of acute leukemia
Bagby, Grover C and Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA138237-02), $393,269USD, 09/30/2008 -- 07/31/2013
 
Gene Replacement Therapy in Hematopoietic Stem Cells
Clapp, David W
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-15), $1,794,260USD, 12/01/1996 -- 06/30/2011
 
Indiana Medical Scientist/Engineer Training Program
Clapp, David W
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5T32GM077229-02), $177,204USD, 07/01/2008 -- 06/30/2013
 
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
Clapp, David W
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074177-12), $325,689USD, 04/01/1997 -- 02/28/2013
 
NF Center: From Animal Models to Therapeutics
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5P50NS052606-05-0002), $218,133USD, 2009
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 3U01NS055849-02S1), $77,000USD, 07/01/2008 -- 06/30/2012
 
Preclinical Testing of Targeted Therapies for Neurofibromas
Clapp, David W
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5U01NS055849-02), $619,319USD, 07/01/2008 -- 06/30/2012